title: Is lateral epicondylitis a new indication for botulinum toxin?
authors.affiliation: Monash Department of Clinical Epidemiology, Cabrini Hospital, Monash University, Malvern, Australia. rachelle.buchbinder@med.monash.edu.au
authors.forename: Rachelle
authors.initials: R
authors.lastname: Buchbinder
authors.forename: Bethan L
authors.initials: BL
authors.lastname: Richards
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D018482:Muscle, Skeletal / Q000294:innervation; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010147:Pain Measurement; D010291:Paresis / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D013716:Tennis Elbow / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A